secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001104659-23-076308
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics elects three Class II directors and ratifies Ernst & Young at annual meeting
--------------------------------------------------------------------------------

- Elected Class II directors: Cynthia Butitta, Timothy Walbert, Alessandro Riva; each term until 2026.
- Butitta: 50.6M for, 0.8M withheld; Walbert: 47.6M for, 3.9M withheld; Riva: 50.7M for, 0.8M withheld.
- Broker non-votes on director election: 3,952,285.
- Ratified Ernst & Young as independent auditor for 2023: 55.4M for, 5K against, 2.8K abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465923076308/0001104659-23-076308-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465923076308/tm2320170d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-076308

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer